Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs.
Animals
Betacoronavirus
/ genetics
COVID-19 Testing
Caco-2 Cells
Chlorocebus aethiops
Clinical Laboratory Techniques
/ economics
Coronavirus Infections
/ diagnosis
Coronavirus M Proteins
Costs and Cost Analysis
Humans
RNA, Viral
/ chemistry
Reverse Transcriptase Polymerase Chain Reaction
/ economics
SARS-CoV-2
Sensitivity and Specificity
Vero Cells
Viral Matrix Proteins
/ genetics
COVID-19
SARS-CoV-2
coronavirus
qRT-PCR detection
test protocol
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
20 Jun 2020
20 Jun 2020
Historique:
received:
18
04
2020
revised:
08
06
2020
accepted:
18
06
2020
entrez:
25
6
2020
pubmed:
25
6
2020
medline:
4
7
2020
Statut:
epublish
Résumé
The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Meanwhile, increased demand for testing has led to a shortage of reagents and supplies and compromised the performance of diagnostic laboratories in many countries. Both the World Health Organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate the interpretation of the test results, especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in diagnostics as well as in research labs using a low-cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infections and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for the quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.
Identifiants
pubmed: 32575728
pii: ijms21124396
doi: 10.3390/ijms21124396
pmc: PMC7352576
pii:
doi:
Substances chimiques
Coronavirus M Proteins
0
RNA, Viral
0
Viral Matrix Proteins
0
membrane protein, SARS-CoV-2
0
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : WI 5086/1-1
Références
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Cell. 2020 May 14;181(4):914-921.e10
pubmed: 32330414
N Engl J Med. 2003 May 15;348(20):1967-76
pubmed: 12690091
Ann Intern Med. 2020 May 5;172(9):619-620
pubmed: 32160299
Nucleic Acids Res. 2017 Jan 4;45(D1):D482-D490
pubmed: 27899678
J Clin Virol. 2020 Jun;127:104381
pubmed: 32344319
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
N Engl J Med. 2020 Mar 26;382(13):1278-1280
pubmed: 32069388
Mol Biol Evol. 1993 May;10(3):512-26
pubmed: 8336541
Nature. 2020 Jul;583(7816):469-472
pubmed: 32408336
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156330